The drug will be funded on the NHS to treat ulcerative colitis under certain conditions More: Final NICE green light for Janssen's Stelara in UC Source: News
read moreThe deal gives GSK access to IDEAYA’s MAT2A, Pol Theta, and Werner Helicase programmes More: GSK and IDEAYA partner in synthetic lethality Source: News
read moreThe move follows data from the RECOVERY trial showing no beneficial effect of the drug in patients hospitalised with COVID-19 More: MHRA suspends COVID-19 hydroxychloroquine trials Source: News
read moreU.K. endorses dexamethasone in COVID-19 hours after groundbreaking data release esagonowsky Tue, 06/16/2020 – 15:18 More: U.K. endorses dexamethasone in COVID-19 hours after groundbreaking data release Source: fierce
read moreADA: Merck, Pfizer’s Steglatro rings up CV safety win but still lags heart-helping peers chelfand Tue, 06/16/2020 – 13:15 More: ADA: Merck, Pfizer's Steglatro rings up CV safety win but still lags heart-helping peers Source: fierce
read moreLilly’s Verzenio shows up Ibrance, hitting its goal in early breast cancer after Pfizer’s drug faltered aliu Tue, 06/16/2020 – 11:35 More: Lilly’s Verzenio shows up Ibrance, hitting its goal in early breast cancer after Pfizer's drug faltered Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals